CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 134 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $455,902 | -13.7% | 79,564 | -28.0% | 0.33% | -19.0% |
| Q3 2023 | $528,305 | +17.5% | 110,524 | +4.4% | 0.41% | +37.6% |
| Q2 2023 | $449,760 | +0.3% | 105,826 | +25.3% | 0.30% | -6.3% |
| Q1 2023 | $448,520 | -5.0% | 84,467 | +12.5% | 0.32% | -19.6% |
| Q4 2022 | $472,000 | -35.5% | 75,107 | +8.3% | 0.39% | -36.8% |
| Q3 2022 | $732,000 | -46.6% | 69,376 | -72.5% | 0.62% | +96.8% |
| Q2 2022 | $1,370,000 | +200.4% | 252,272 | +407.9% | 0.32% | +2.3% |
| Q1 2022 | $456,000 | -15.1% | 49,674 | +39.6% | 0.31% | -15.2% |
| Q4 2021 | $537,000 | -31.5% | 35,592 | +8.4% | 0.36% | -32.9% |
| Q3 2021 | $784,000 | – | 32,836 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $10,174,000 | 6.39% |
| 72 Investment Holdings, LLC | 474,067 | $7,154,000 | 6.35% |
| Velan Capital Investment Management LP | 210,695 | $3,179,000 | 2.47% |
| PFM Health Sciences, LP | 4,092,309 | $59,418,000 | 2.02% |
| Monashee Investment Management LLC | 504,377 | $7,611,000 | 1.88% |
| CloudAlpha Capital Management Limited/Hong Kong | 415,000 | $6,262,000 | 1.49% |
| Avidity Partners Management LP | 2,674,067 | $40,352,000 | 0.86% |
| Rokos Capital Management LLP | 570,359 | $8,604,000 | 0.52% |
| Green Alpha Advisors, LLC | 35,592 | $537,000 | 0.36% |
| Tekla Capital Management LLC | 699,377 | $9,875,000 | 0.32% |